doi:10.3969/j.issn.1004-583X.2022.09.016

Abstract

CLC Number:

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2022.09.016

https://huicui.hebmu.edu.cn/EN/Y2022/V37/I9/842

References 45

[1]	Lau WB, Ohashi K, Wang Y, et al. Role of adipokines in cardiovascular disease[J]. Circ J, 2017, 81(7):920-928. doi: 10.1253/circj.CJ-17-0458 pmid: 28603178
[2]	Recinella L, Orlando G, Ferrante C, et al. Adipokines:New potential therapeutic target for obesity and metabolic, rheumatic, and cardiovascular diseases[J]. Front Physiol, 2020, 11: 578966. doi: 10.3389/fphys.2020.578966 URL
[3]	Wilson MR, Easterbrook-Smith SB. Clusterin is a secreted mammalian chaperone[J]. Trends Biochem Sci, 2000, 25(3):95-98. pmid: 10694874
[4]	Wittwer J, Bradley D. Clusterin and its role in insulin resistance and the cardiometabolic syndrome[J]. Front Immunol, 2021, 12:612496. doi: 10.3389/fimmu.2021.612496 URL
[5]	Blaschuk O, Burdzy K, Fritz IB. Purification and characterization of a cell-aggregating factor (clusterin), the major glycoprotein in ram rete testis fluid[J]. J Biol Chem, 1983, 258(12):7714-7720. pmid: 6863260
[6]	卜浩. sCLU在胰腺癌组织中的表达与其临床意义研究[D]. 湖南师范大学, 2020.
[7]	Park S, Mathis KW, Lee IK. The physiological roles of apolipoprotein J/clusterin in metabolic and cardiovascular diseases[J]. Rev Endocr Metab Disord, 2014, 15(1):45-53. doi: 10.1007/s11154-013-9275-3 URL
[8]	Trougakos IP, Gonos ES. Regulation of clusterin/apolipoprotein J, a functional homologue to the small heat shock proteins, by oxidative stress in ageing and age-related diseases[J]. Free Radic Res, 2006, 40(12):1324-1334. doi: 10.1080/10715760600902310 URL
[9]	Boel N, Edkins A. Regulation of the extracellular matrix by heat shock proteins and molecular chaperones[J]. Heat Shock Prot Imm Syst, 2018:97-121.
[10]	Cunin P, Beauvillain C, Miot C, et al. Clusterin facilitates apoptotic cell clearance and prevents apoptotic cell-induced autoimmune responses[J]. Cell Death Dis, 2016, 7(5): e2215.
[11]	Hong SW, Lee J, Kim MJ, et al. Clusterin protects lipotoxicity-induced apoptosis via upregulation of autophagy in insulin-secreting cells[J]. Endocrinol Metab (Seoul), 2020, 35(4):943-953. doi: 10.3803/EnM.2020.768 URL
[12]	Lee J, Hong SW, Kwon H, et al. Resveratrol, an activator of SIRT1, improves ER stress by increasing clusterin expression in HepG2 cells[J]. Cell Stress Chaperones, 2019, 24(4):825-833. doi: 10.1007/s12192-019-01012-z URL
[13]	Xiao Y, Zeng M, Yin L, et al. Clusterin increases mitochondrial respiratory chain complex I activity and protects against hexavalent chromium-induced cytotoxicity in L-02 hepatocytes[J]. Toxicol Res, 2018, 8(1):15-24. doi: 10.1039/C8TX00231B URL
[14]	Ma Y, Li S, Tang S, et al. Clusterin protects against Cr(VI)-induced oxidative stress-associated hepatotoxicity by mediating the Akt-Keap1-Nrf2 signaling pathway[J]. Environ Sci Pollut Res Int, 2022, 29(34):52289-52301. doi: 10.1007/s11356-022-19118-w URL
[15]	Zhang Y, Zhang Y, Xiao Y, et al. Expression of clusterin suppresses Cr(VI)-induced premature senescence through activation of PI3K/AKT pathway[J]. Ecotoxicol Environ Saf, 2019, 183:109465. doi: 10.1016/j.ecoenv.2019.109465 URL
[16]	Li Y, Song YQ, Zhang Y, et al. Over-expression of apolipoprotein J inhibits cholesterol crystal-Induced inflammatory responses via suppressing NLRP3 inflammasome activation in THP-1 macrophages[J]. Folia Biol (Praha), 2021, 67(5-6):183-190.
[17]	Riwanto M, Rohrer L, Roschitzki B, et al. Altered activation of endothelial anti-and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling[J]. Circulation, 2013, 127(8):891-904. doi: 10.1161/CIRCULATIONAHA.112.108753 URL
[18]	Iłżecka J, Iłżecki M, Grabarska A, et al. Clusterin as a potential marker of brain ischemia-reperfusion injury in patients undergoing carotid endarterectomy[J]. Ups J Med Sci, 2019, 124(3):193-198. doi: 10.1080/03009734.2019.1646359 URL
[19]	Zhu H, Liu M, Zhai T, et al. High serum clusterin levels are associated with premature coronary artery disease in a Chinese population[J]. Diabetes Metab Res Rev, 2019, 35(4):e3128. doi: 10.1002/dmrr.3128 URL
[20]	Kang M, Seong Y, Mahmud J, et al. Obscurin and Clusterin Elevation in Serum of Acute Myocardial Infarction Patients[J]. Bull Korean Chem Soc, 2020, 41(3):266-273. doi: 10.1002/bkcs.11955 URL
[21]	Traxler D, Spannbauer A, Einzinger P, et al. Early elevation of systemic plasma clusterin after reperfused acute myocardial infarction in a preclinical porcine model of ischemic heart disease[J]. Int J Mol Sci, 2020, 21(13):4591. doi: 10.3390/ijms21134591 URL
[22]	Wu D, Zhang K, Hu P. The role of autophagy in acute myocardial infarction[J]. Front Pharmacol, 2019, 10:551. doi: 10.3389/fphar.2019.00551 pmid: 31214022
[23]	Turkieh A, Porouchani S, Beseme O, et al. Increased clusterin levels after myocardial infarction is due to a defect in protein degradation systems activity[J]. Cell Death Dis, 2019, 10(8): 608. doi: 10.1038/s41419-019-1857-x pmid: 31406108
[24]	Pavo N, Lukovic D, Zlabinger K, et al. Intrinsic remote conditioning of the myocardium as a comprehensive cardiac response to ischemia and reperfusion[J]. Oncotarget, 2017, 8(40) : 67227-67240. doi: 10.18632/oncotarget.18438 pmid: 28978029
[25]	梁鹏. 急性冠脉综合征患者血清簇集蛋白水平与冠脉狭窄程度相关性研究[D]. 河北医科大学, 2019.
[26]	Eggers KM, Lindhagen L, Baron T, et al. Erratum to: Predicting outcome in acute myocardial infarction: An analysis investigating 175 circulating biomarkers[J]. Eur Heart J Acute Cardiovasc Care, 2022, 11(1):88. doi: 10.1093/ehjacc/zuab107 URL
[27]	Bass-Stringer S, Ooi JYY, McMullen JR. Clusterin is regulated by IGF1-PI3K signaling in the heart: Implications for biomarker and drug target discovery, and cardiotoxicity[J]. Arch Toxicol, 2020, 94:1763-1768. doi: 10.1007/s00204-020-02709-2 pmid: 32172307
[28]	Koller L, Richter B, Winter MP, et al. Clusterin/apolipoprotein J is independently associated with survival in patients with chronic heart failure[J]. Clin Lipidol, 2017, 11(1):178-184.
[29]	Turkieh A, Fertin M, Bouvet M, et al. Expression and implication of clusterin in left ventricular remodeling after myocardial infarction[J]. Circ Heart Fail, 2018, 11(6):e004838. doi: 10.1161/CIRCHEARTFAILURE.117.004838 URL
[30]	Sirtori CR, Ruscica M, Calabresi L, et al. HDL therapy today: From atherosclerosis, to stent compatibility to heart failure[J]. Ann Med, 2019, 51(7-8):345-359. doi: 10.1080/07853890.2019.1694695 pmid: 31729238
[31]	Jenča D, Melenovský V, Stehlik J, et al. Heart failure after myocardial infarction: Incidence and predictors[J]. ESC Heart Fail, 2020, 8(1):222-237.
[32]	杨斐然. 原发性老年高血压患者血清簇集蛋白水平与血管内皮功能的相关性[D]. 河北医科大学, 2019.
[33]	Zeng S, Han M, Jiang M, et al. Serum complement proteomics reveal biomarkers for hypertension disorder of pregnancy and the potential role of clusterin[J]. Reprod Biol Endocrinol, 2021, 19(1):56. doi: 10.1186/s12958-021-00742-z URL
[34]	Kocatürk M, Baykal AT, Turkseven S, et al. Evaluation of serum and ascitic fluid proteomes in dogs with dilated cardiomyopathy[J]. Kafkas Uni Vet Fak Derg, 2016, 22: 273-279.
[35]	Roura S, Gámez-Valero A, Lupón J, et al. Proteomic signature of circulating extracellular vesicles in dilated cardiomyopathy[J]. Lab Invest, 2018, 98(10):1291-1299. doi: 10.1038/s41374-018-0044-5 pmid: 29540862
[36]	Kourelis TV, Dasari SS, Dispenzieri A, et al. A proteomic atlas of cardiac amyloid plaques[J]. JACC Cardio Oncol, 2020, 2(4):632-643.
[37]	McLaughlin L, Zhu G, Mistry M, et al. Apolipoprotein J/clusterin limits the severity of murine autoimmune myocarditis[J]. Clin Invest, 2000, 106(9):1105-1113. doi: 10.1172/JCI9037 URL
[38]	Pereira RM, Mekary RA, da Cruz Rodrigues KC, et al. Protective molecular mechanisms of clusterin against apoptosis in cardiomyocytes[J]. Heart Fail Rev, 2018, 23(1):123-129. doi: 10.1007/s10741-017-9654-z pmid: 28948410
[39]	Guan Q, Li S, Yip G, et al. Decrease in donor heart injury by recombinant clusterin protein in cold preservation with University of Wisconsin solution[J]. Surgery, 2012, 151(3):364-371. doi: 10.1016/j.surg.2011.09.032 URL
[40]	Du J, Liu L, Yu B, et al. Clusterin (apolipoprotein J) facilitates NF-κB and Bax degradation and prevents I/R injury in heart transplantation[J]. Int J Clin Exp Pathol, 2018, 11(3):1186-1196.
[41]	Hollander Z, Lazárová M, Lam KK, et al. Proteomic biomarkers of recovered heart function[J]. Eur J Heart Fail, 2014, 16:551-559. doi: 10.1002/ejhf.65 pmid: 24574204
[42]	Oh GS, Yoon J, Kim G, et al. Regulation of adipocyte differentiation by clusterin-mediated Krüppel-like factor 5 stabilization[J]. FASEB J, 2020, 34(12): 16276-16290. doi: 10.1096/fj.202000551RR URL
[43]	Peng M, Deng J, Zhou S, et al. The role of clusterin in cancer metastasis[J]. Cancer Manag Res, 2019, 11:2405-2414. doi: 10.2147/CMAR.S196273 pmid: 31114318
[44]	Wilson MR, Zoubeidi A. Clusterin as a therapeutic target[J]. Expert Opin Ther Targets, 2017, 21(2):201-213. doi: 10.1080/14728222.2017.1267142 URL
[45]	Foster EM, Dangla-Valls A, Lovestone S, et al. Clusterin in Alzheimer's disease: Mechanisms, genetics, and lessons from other pathologies[J]. Front Neurosci, 2019, 13:164. doi: 10.3389/fnins.2019.00164 URL

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 45

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	. [J]. Clinical Focus, 2024, 39(2): 188-192.
[2]	Huang Yuling, Zhang Xinyue, Rong Pingping, Yang Wenqi, Cao Xinying, Xing Cainai, Wang Zhijun, Liu Ning. Correlation analysis of Non-HDL-C/HDL-C and NHR with the severity of coronary artery disease [J]. Clinical Focus, 2024, 39(2): 115-120.
[3]	Wang Yihan, Qin Xuyan, Han Xuanze, Wang Yingjie, Gao Feifei, Chen Chunhong, Zhang Lingnan, Zhang Fang. Efficacy and safety of rivaroxaban therapy in elderly patients with non-valvular atrial fibrillation who had a HASBLED score≥3 [J]. Clinical Focus, 2024, 39(2): 121-124.
[4]	. [J]. Clinical Focus, 2024, 39(2): 168-171.
[5]	. [J]. Clinical Focus, 2024, 39(1): 75-79.
[6]	. [J]. Clinical Focus, 2024, 39(1): 80-83.
[7]	Liu Yi, Cui Kun, Liu Chang, Zhao Haotian, Li Li, Xue Hongyuan. Correlation between serum secreted frizzled-related protein 5 and early renal damage in patients with essential hypertension [J]. Clinical Focus, 2023, 38(12): 1073-1077.
[8]	Jiang Ji, Zhu Xiaogang, Jiang Shan, Dawa Zhaba, Cen Qiang. Risk factors of proteinuria in hypertensive people living at high altitude for generations [J]. Clinical Focus, 2023, 38(12): 1086-1090.
[9]	Li Lisha, Shen Xianghui, Liu Yanhui, Ren Yanbin. Aortic root anatomy and atrial septal mobility analyzed by transesophageal echocardiography [J]. Clinical Focus, 2023, 38(11): 1012-1015.
[10]	Li Zhiyong. Transient peripheral carotid inflammation syndrome diagnosed by ultrasonography: A case report and literature review [J]. Clinical Focus, 2023, 38(11): 1027-1030.
[11]	Xu Yang, Xue Ling. Influencing factors for mild cognitive impairment in type H hypertension patients combined with type 2 diabetes mellitus [J]. Clinical Focus, 2023, 38(10): 887-892.
[12]	Zhang Yongzhi, Li Yanmin, Ma Xiaowen, Gu Ping. Aortic dissection with weakness and numbness of both lower limbs as the first manifestation: A case report and literature review [J]. Clinical Focus, 2023, 38(10): 912-916.
[13]	Wang Jiaqi, Xie Yuetao, Gao Man, Song Xuelian, Zhang Feifei, Dang Yi, Qi Xiaoyong. Treatment of variant angina pectoris guided by the optical coherence tomography: A case report and literature review [J]. Clinical Focus, 2023, 38(10): 917-921.
[14]	Yang Changlin, Cao Shufeng, Qiao Lian, Zhao Huimin. Type I Kounis syndrome caused by drug allergy: A case report [J]. Clinical Focus, 2023, 38(10): 922-925.
[15]	Duan Fang, Cui Wei. Application principles of vasodilators in the treatment of acute heart failure [J]. Clinical Focus, 2023, 38(9): 773-778.